Drugs / MMF 2 g + full-dose Neoral (FDN) + corticosteroids
MMF 2 g + full-dose Neoral (FDN) + corticosteroids
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00099736 | May 2003 → Sep 2005 | — | Novartis Pharmaceuticals | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMF 2 g + full-dose Neoral (FDN) + corticosteroids | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00099736 ↗ |